Treatment Selection for Patients With NSCLC With High PD-L1 Expression

CME: 0.5

January 31, 2021
KEYWORDS Primary Care
/ Print / Reprints /
| Share More
/ Text Size+

This activity has been designed to address the educational needs of medical oncologists. It may also be of benefit to other healthcare professionals (HCPs) who manage patients with non-small cell lung cancer (NSCLC).

Post a comment to this article